Abstract
NAMPT may represent a novel target for drug discovery in various therapeutic areas, including oncology and inflammation. Additionally, recent work has suggested that targeting NAMPT has potential in treating axon degeneration. In this work, publicly available X-ray co-crystal structures of NAMPT and the structures of two known NAMPT inhibitors were used as the basis for a structure- and ligand-based virtual screening campaign. From this, two novel series of NAMPT inhibitors were identified, one of which showed a statistically significant protective effect when tested in a cellular model of axon degeneration.
Original language | English |
---|---|
Pages (from-to) | 2920-2926 |
Number of pages | 7 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 26 |
Issue number | 12 |
DOIs | |
Publication status | Published - 15 Jun 2016 |
Keywords
- Axon degeneration
- Molecular docking
- NAMPT
- Similarity searching
- Virtual screening
Research Beacons, Institutes and Platforms
- Manchester Cancer Research Centre